Anagha Rajesh, the 24-year-old founder of BioCompute, has announced the relocation of her deep-tech startup from Bengaluru, India, to San Francisco, United States. The company, which is pioneering a novel method of digital data storage using DNA, is making the move to secure an ecosystem better suited for high-risk, high-reward technological innovation.
The Vision: DNA Data Storage
Founded in 2024, BioCompute aims to revolutionize data storage by leveraging DNA's natural capacity to hold vast amounts of information efficiently and compactly. The startup is developing DNA data storage chips, envisioning a future where massive digital data could be stored within tiny biological systems, significantly reducing the energy and physical footprint of traditional data centers.
Why the Move? Ecosystem and Capital
Rajesh explained that while India possesses significant talent for deep-tech breakthroughs, its ecosystem currently lacks the necessary risk-taking capital and support for highly experimental technologies. She highlighted a key difference in investor focus:
"They [the people in San Francisco] were not as concerned about revenue. They were more concerned about what I would need to follow this through."
This contrasts with India's approach, which Rajesh describes as often preferring to adapt established Western technologies rather than investing in groundbreaking, unproven ventures. She argues that building a new-age data storage hardware company capable of challenging industry giants requires an ecosystem built on abundance and a willingness to make high-risk bets.
India's Challenge: Capital, Not Talent
Vyom Bhatia, who initially shared Rajesh's story, echoed her sentiments, stating that India's primary challenge isn't a shortage of skilled individuals but a lack of capital for ambitious deep-tech projects. Despite BioCompute having raised over ₹5 crore from investors like WTF Fund, Grad Capital, and 1517 Fund, and developing an end-to-end prototype in India, the next phase of product development and customer engagement demands a different environment.
Impact on Bengaluru Operations
The relocation necessitates shutting down BioCompute's Bengaluru operations and parting ways with the foundational team. Rajesh described these conversations as some of the most difficult moments in her journey, acknowledging the dedication of her team to shaping data infrastructure.
The company's next chapter in San Francisco will focus intensely on product development, building its DNA storage chips, and bringing this innovative technology to market.